Related Experiment Video
Updated: Nov 5, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
The outstanding role of miR-132-3p in carcinogenesis of solid tumors
Milad Rafat1, Mahta Moraghebi1, Masoumeh Afsa2
1Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Abstract:
MicroRNAs are a group of short non-coding RNAs (miRNAs), which are epigenetically involved in gene expression and other cellular biological processes and can be considered as potential biomarkers for cancer detection and support for treatment management. This review aims to amass the evidence to reach the molecular mechanism and clinical significance of miR-132 in different types of cancer. Dysregulation of miR-132 level in various types of malignancies, including hepatocellular carcinoma, breast cancer, colorectal cancer, gastric cancer, lung cancer, prostate cancer, osteosarcoma, pancreatic cancer, and ovarian cancer have reported, significantly decrease in its level, which can be indicated to its function as a tumor suppressor. miR-132 is involved in cell proliferation, migration, and invasion through cell cycle pathways, such as PI3K, TGFβ or hippo signaling pathways, or on oncogenes such as Ras, AKT, mTOR, glycolysis. miR-132 could be potentially a candidate as a valuable biomarker for prognosis in various cancers. Through this study, we proposed that miR-132 can potentially be a candidate as a prognostic marker for early detection of tumor development, progression, as well as metastasis.
Insights
MicroRNAs (miRNAs) regulate genes and can signal cancer. This review highlights miR-132
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are short non-coding RNAs involved in epigenetic gene regulation.
- miRNAs play roles in cellular processes and are investigated as cancer biomarkers.
- Dysregulation of specific miRNAs is linked to various cancer types and progression.
Purpose of the Study:
- To review the molecular mechanisms and clinical significance of miR-132 in diverse cancers.
- To consolidate evidence on miR-132's role as a potential tumor suppressor and biomarker.
Main Methods:
- Comprehensive literature review of studies investigating miR-132 in cancer.
- Analysis of reported dysregulation patterns and functional roles of miR-132.
- Examination of miR-132's involvement in cancer-related signaling pathways.
Main Results:
- miR-132 levels are significantly decreased in multiple cancers, suggesting a tumor suppressor function.
- miR-132 influences cell proliferation, migration, and invasion via pathways like PI3K, TGFβ, hippo, and oncogenes (Ras, AKT, mTOR).
- Reduced miR-132 is associated with tumor development, progression, and metastasis across various malignancies.
Conclusions:
- miR-132 acts as a tumor suppressor in numerous cancer types.
- miR-132 is a promising candidate biomarker for early cancer detection and prognosis.
- Further research into miR-132 could enhance cancer treatment management and monitoring.
More Related Videos
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...

